Author

J. Hartwig

Observed name: J Hartwig

Institution: Infirmerie Protestante

Observed institutions: Hôpital Lyon Sud, Infirmerie Protestante

OpenAlex ID: A5110026668

Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers

2019 · M. Karoui, A. Rullier, et al. · Annals of Surgery · 148

Improved sphincter preservation of low rectal cancer with high dose preoperative radiotherapy: the lyon R96-02 randomized trial

2003 · J Gerard, O Chapet, et al. · International Journal of Radiation Oncology*Biology*Physics · 27

LBA1 Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate: A proof of concept study - Preliminary results of FFCD 1703 POCHI trial

2024 · D. Tougeron, J.F. Emile, et al. · Annals of Oncology · 7

502O Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: Preliminary results of FFCD 1703 POCHI trial

2024 · D. Tougeron, J-F. Emile, et al. · Annals of Oncology · 3

Works count: 4

Citation count: 184

H-index: 3

I10-index: 2